1. Home
  2. JVA vs ALLR Comparison

JVA vs ALLR Comparison

Compare JVA & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.17

Market Cap

17.8M

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$0.95

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
ALLR
Founded
1971
2004
Country
United States
United States
Employees
92
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
19.3M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
JVA
ALLR
Price
$3.17
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.50
AVG Volume (30 Days)
61.9K
201.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.57%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.48
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.76
$0.61
52 Week High
$9.93
$2.35

Technical Indicators

Market Signals
Indicator
JVA
ALLR
Relative Strength Index (RSI) 45.30 47.37
Support Level $3.00 $0.80
Resistance Level $4.38 $0.96
Average True Range (ATR) 0.14 0.10
MACD 0.03 0.01
Stochastic Oscillator 83.33 51.33

Price Performance

Historical Comparison
JVA
ALLR

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: